Join
Live feed
·
INSIDERFilingvia Quantisnow
Sigilon Therapeutics Inc. logo

SEC Form 4: Vivaldi Coelho Rogerio was granted 50,000 shares, increasing direct ownership by 213% to 73,461 units

ByQuantisnow·Wall Street's wire, on your screen.
SGTX· Sigilon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGTX (Sigilon Therapeutics Inc.) and more on Quantisnow.